FDAnews Device Daily Bulletin
Medical Devices / Regulatory Affairs

Endologix Appoints New Chief Commercial Officer

Jan. 15, 2019
A A

Endologix, a developer of aortic disorder treatments, named John Zehren as its new chief commercial officer.

Zehren brings more than twenty years of experience in the medical device industry, most recently as Medtronic Neurovascular’s vice president of sales in the Americas.

He previously served as vice president of sales at Covidien and ev3. Earlier in his career, he spent over a decade at Edwards Lifesciences.

View today's stories